Determination of quantitative and site-specific DNA methylation of perforin by pyrosequencing

BMC Research Notes

Volumn 2, Issue , 2009, Pages

  Narasimhan, Supraja ^a   Falkenberg, Virginia R ^a   Khin, Maung M ^a   Rajeevan, Mangalathu S ^a  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 77049100573     PISSN: None     EISSN: 17560500     Source Type: Journal    
DOI: 10.1186/1756-0500-2-104     Document Type: Article

References (24)

1. Systemic and local expression of perforin in lymphocyte subsets in acute and chronic rheumatoid arthritis. G Gulan J Ravlic-Gulan N Strbo V Sotosek B Nemec D Matovinovic, et al. J Rheumatol 2003 30 660 670 12672182
2. Demethylation of promoter regulatory elements contributes to perforin overexpression in CD4+ lupus T cells. MJ Kaplan Q Lu A Wu J Attwood B Richardson, J Immunol 2004 172 3652 3661 15004168
3. Perforin expression is upregulated in the epidermis of psoriatic lesions. M Kastelan ML Prpic F Gruber G Zamolo G Zauhar M Coklo, et al. Br J Dermatol 2004 151 831 836 10.1111/j.1365-2133.2004.06168.x 15491424
4. Effects of CD134 monoclonal antibody on hemolysis activities and expression of perforin in peripheral blood mononuclear cells of systemic lupus erythematosus patients. M Li Q Yang Y Zhang, Hybridoma (Larchmt) 2007 26 191 200 10.1089/hyb.2007.010 17725380
5. DNA methylation and chromatin structure regulate T cell perforin gene expression. Q Lu A Wu D Ray C Deng J Attwood S Hanash, et al. J Immunol 2003 170 5124 5132 12734359
6. Chronic fatigue syndrome is associated with diminished intracellular perforin. KJ Maher NG Klimas MA Fletcher, Clin Exp Immunol 2005 142 505 511 16297163
7. Changes of cytolytic cells and perforin expression in patients with posttraumatic stress disorder. I Skarpa G Rubesa L Moro D Manestar M Petrovecki D Rukavina, Croat Med J 2001 42 551 555 11596172
8. Differential-display PCR of peripheral blood for biomarker discovery in chronic fatigue syndrome. M Steinau ER Unger SD Vernon JF Jones MS Rajeevan, J Mol Med 2004 82 750 755 10.1007/s00109-004-0586-4 15490094
9. The complex issue of regulating perforin expression. JA Trapani I Voskoboinik, Trends Immunol 2007 28 243 245 10.1016/j.it.2007.04.003 17466595
10. Quantitation of site-specific HPV 16 DNA methylation by pyrosequencing. MS Rajeevan DC Swan K Duncan DR Lee JR Limor ER Unger, J Virol Methods 2006 138 170 176 10.1016/j.jviromet.2006.08.012 17045346
11. Microsoft Word macro for analysis of cytosine methylation by the bisulfite deamination reaction. R Singal SR Grimes, Biotechniques 2001 30 116 120 11196301
12. Optimizing annealing temperature overcomes bias in bisulfite PCR methylation analysis. L Shen Y Guo X Chen S Ahmed JP Issa, Biotechniques 2007 42 48 50, 52. 10.2144/000112312 17269485
13. Sensitive and quantitative universal Pyrosequencing methylation analysis of CpG sites. S Colella L Shen KA Baggerly JP Issa R Krahe, Biotechniques 2003 35 146 150 12866414
14. Structure of the human perforin gene. A simple gene organization with interesting potential regulatory sequences. MG Lichtenheld ER Podack, J Immunol 1989 143 4267 4274 2480391
15. Interleukin 2 receptor signaling regulates the perforin gene through signal transducer and activator of transcription (Stat)5 activation of two enhancers. J Zhang I Scordi MJ Smyth MG Lichtenheld, J Exp Med 1999 190 1297 1308 10544201 10.1084/jem.190.9.1297 (Pubitemid 29522213)
16. Methodological improvements of pyrosequencing technology. B Gharizadeh M Akhras N Nourizad M Ghaderi K Yasuda P Nyren, et al. J Biotechnol 2006 124 504 511 10.1016/j.jbiotec.2006.01.025 16530870
17. Analysis of read length limiting factors in Pyrosequencing chemistry. F Mashayekhi M Ronaghi, Anal Biochem 2007 363 275 287 17343818 10.1016/j.ab.2007.02.002 (Pubitemid 46428223)
18. Precision and performance characteristics of bisulfite conversion and real-time PCR (MethyLight) for quantitative DNA methylation analysis. S Ogino T Kawasaki M Brahmandam M Cantor GJ Kirkner D Spiegelman, et al. J Mol Diagn 2006 8 209 217 16645207 10.2353/jmoldx.2006.050135 (Pubitemid 43811244)
19. De novo quantitative bisulfite sequencing using the pyrosequencing technology. JM Dupont J Tost H Jammes IG Gut, Anal Biochem 2004 333 119 127 10.1016/j.ab.2004.05.007 15351288
20. Optimization of quantitative MGMT promoter methylation analysis using pyrosequencing and combined bisulfite restriction analysis. T Mikeska C Bock O El-Maarri A Hubner D Ehrentraut J Schramm, et al. J Mol Diagn 2007 9 368 381 17591937 10.2353/jmoldx.2007.060167 (Pubitemid 47305073)
21. DNA methylation analysis by pyrosequencing. J Tost IG Gut, Nat Protoc 2007 2 2265 2275 10.1038/nprot.2007.314 17853883
22. Comprehensive high-throughput arrays for relative methylation (CHARM). RA Irizarry C Ladd-Acosta B Carvalho H Wu SA Brandenburg JA Jeddeloh, et al. Genome Res 2008 18 780 790 18316654 10.1101/gr.7301508 (Pubitemid 351645068)
23. Quantitative analysis of SNRPN(correction of SRNPN) gene methylation by pyrosequencing as a diagnostic test for Prader-Willi syndrome and Angelman syndrome. HE White VJ Durston JF Harvey NC Cross, Clin Chem 2006 52 1005 1013 10.1373/clinchem.2005.065086 16574761
24. Evaluation of a potential epigenetic biomarker by quantitative methyl-single nucleotide polymorphism analysis. K Uhlmann A Brinckmann MR Toliat H Ritter P Nurnberg, Electrophoresis 2002 23 4072 4079 10.1002/elps.200290023 12481262